(Q34592760)

3 August 2017

0 references

A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma (English)

1 reference

3 August 2017

0 references

1 reference

Nabeel Pervaiz

1

1 reference

3 August 2017

Nigel Colterjohn

2

1 reference

3 August 2017

Forough Farrokhyar

3

1 reference

3 August 2017

Richard Tozer

4

1 reference

3 August 2017

Alvaro Figueredo

5

1 reference

3 August 2017

Michelle Ghert

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

3 August 2017

number of pages

9

1 reference

inferred from page(s)

published in

Cancer

1 reference

3 August 2017

volume

113

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

573-581

1 reference

Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Association of local recurrence with subsequent survival in extremity soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Localized Extremity Soft Tissue Sarcoma: Improved Knowledge With Unchanged Survival Over Time

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Benefit of surgical treatment of lung metastasis in soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Incorporating variations in the quality of individual randomized trials into meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Adjuvant chemotherapy for soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23592

7 January 2021

Identifiers

DOI

10.1002/CNCR.23592

1 reference

3 August 2017

1 reference